Creative Biolabs leverages our world-class discovery and development experience, as well as our significant excellence, to offer effective and innovative NatAb™ platform for antibody discovery. Our NatAb™ platform uses droplet microfluidics to isolate single B cells exhibiting functional antibodies, which is completely different from the existing hybridoma or phage display platforms. It enables the ultra-high throughput identification of the promising antibodies from single B cells and provides comprehensive information of natural heavy and light chain pairing, which takes new valuable insights into diagnostics and therapeutic antibody discovery.